ResearchPod Summary
Hypertensive disorders of pregnancy—including gestational hypertension, preeclampsia, and eclampsia—are major contributors to maternal and infant morbidity and mortality in the United States. In light of rising case rates, the US Preventive Services Task Force (USPSTF) conducted a systematic review to evaluate the benefits and harms of various screening approaches. Based on this evidence, the USPSTF issues a Grade B recommendation, advising that all pregnant persons undergo regular blood pressure measurements throughout pregnancy as a standard part of prenatal care.
The USPSTF reviewed evidence regarding the accuracy and effectiveness of screening via blood pressure measurement, focusing on differences in gestational timing, frequency, and alternative modalities (such as home monitoring or varying visit schedules). While the foundational benefits of treating diagnosed hypertensive disorders are well-established, the review specifically looked for evidence comparing different screening protocols to standard office-based care. The review also considered the role of proteinuria screening and the impact of health inequities on outcomes for Black and Native American/Alaska Native populations.
The USPSTF concluded that there is a substantial net benefit to screening for hypertensive disorders using routine blood pressure measurements. Evidence from several randomized trials indicated that alternative screening strategies—such as home blood pressure monitoring or reduced prenatal visit schedules—did not demonstrate superior performance or significant differences in health outcomes compared to standard office-based screenings. Furthermore, the evidence does not support routine point-of-care urine testing for proteinuria, as it has low accuracy for predicting health outcomes. The potential harms associated with standard blood pressure screening were deemed minimal.
Hypertensive disorders are a leading cause of pregnancy-related deaths, with a significant portion of these fatalities occurring postpartum. The USPSTF emphasizes that screening alone is not sufficient to address persistent racial and ethnic health inequities; effective management requires consistent prenatal and postpartum surveillance, addressing structural barriers to care, and ensuring equitable access to high-quality treatment. Clinicians are urged to individualize care and maintain high awareness of risk factors to improve outcomes for the most vulnerable populations.
AI-generated third-party summary by ResearchPod. Not official content or an endorsement by the paper authors or affiliated organizations.